Bicara Therapeutics Inc.

BCAX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jul 10, 2026 FORM 4
4 Jul 10, 2026 FORM 4
144 Jul 10, 2026
144 Jul 8, 2026
144 Jul 8, 2026
144 Jul 8, 2026
144 Jul 7, 2026
144 Jun 25, 2026
4 Jun 10, 2026
4 Jun 10, 2026 FORM 4
4 Jun 10, 2026 FORM 4
4 Jun 10, 2026 FORM 4
4 Jun 10, 2026 FORM 4
4 Jun 10, 2026 FORM 4
4 Jun 10, 2026 FORM 4
8-K Jun 10, 2026 8-K
144 Jun 1, 2026
4 May 26, 2026 FORM 4
144 May 26, 2026
8-K May 21, 2026 8-K
144 May 21, 2026
4 May 20, 2026 FORM 4
4 May 18, 2026 FORM 4
144 May 18, 2026
SCHEDULE 13G/A May 15, 2026
← Newer Page 2 of 11 · 263 filings Older →